Carlisle Companies Incorporated

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

Ford Motor, PG&E, Amarin: 'Mad Money' Lightning Round

JIM CRAMER

By Scott Rutt
Dec 7, 2017 6:42 AM EST

Latest News

PRESS RELEASES

By Business Wire
Jun 2, 2021 5:01 PM EDT

PRESS RELEASES

By PR Newswire
May 25, 2021 7:01 AM EDT

PRESS RELEASES

By PR Newswire
May 16, 2021 1:15 PM EDT

PRESS RELEASES

By PR Newswire
May 6, 2021 7:05 AM EDT

PRESS RELEASES

By Business Wire
May 4, 2021 4:05 PM EDT

PRESS RELEASES

By PR Newswire
May 3, 2021 9:05 AM EDT

PRESS RELEASES

By Business Wire
Apr 20, 2021 3:00 PM EDT

PRESS RELEASES

By PR Newswire
Apr 20, 2021 8:30 AM EDT

PRESS RELEASES

By PR Newswire
Apr 19, 2021 5:00 PM EDT

PRESS RELEASES

By Business Wire
Apr 12, 2021 11:50 AM EDT

PRESS RELEASES

By Business Wire
Apr 8, 2021 6:00 AM EDT

PRESS RELEASES

By PR Newswire
Mar 16, 2021 12:40 PM EDT

PRESS RELEASES

By PR Newswire
Mar 5, 2021 8:30 AM EST

PRESS RELEASES

By Business Wire
Feb 12, 2021 4:05 PM EST

PRESS RELEASES

By Business Wire
Feb 2, 2021 4:05 PM EST

PRESS RELEASES

By Business Wire
Feb 2, 2021 4:05 PM EST

PRESS RELEASES

By PR Newswire
Jan 25, 2021 8:45 AM EST

PRESS RELEASES

By Business Wire
Jan 21, 2021 9:00 AM EST

PRESS RELEASES

By PR Newswire
Jan 7, 2021 9:00 AM EST

PRESS RELEASES

By Business Wire
Jan 4, 2021 9:00 AM EST

PRESS RELEASES

By Business Wire
Dec 14, 2020 10:30 AM EST

PRESS RELEASES

By PR Newswire
Dec 7, 2020 8:00 AM EST

PRESS RELEASES

By PR Newswire
Nov 19, 2020 7:00 AM EST

PRESS RELEASES

By PR Newswire
Nov 16, 2020 8:30 AM EST

Trade with Jim Cramer 14 Days Free

LATEST NEWS

Ford, Cadence Systems, Carlisle, Teledyne: 'Mad Money' Lightning Round

Latest News

Carlisle Companies Announces Construction Of New TPO Manufacturing Line

Carlisle TyrFil Supports Reforestation Efforts In Southeast Florida

New Meta-Analysis Of Patients With Acute Coronary Syndrome Shows Nearly Half Of Recurrent Major Adverse Cardiovascular Events At One Year Occur Within The First 90 Days

CSL Behring Announces Closing Of Global Commercialization And License Agreement With UniQure For Etranacogene Dezaparvovec

Carlisle Companies Declares Regular Quarterly Dividend

Seqirus Presents New Phase 3 Clinical Data Supporting Use Of Cell-Based Seasonal Influenza Vaccine In Children Six Months Through <4 Years Of Age

Carlisle Companies Announces Plans For New Polyiso Insulation Manufacturing Facility In Sikeston, Missouri

Seqirus Publishes New Real-World Evidence Supporting The Effectiveness Of Adjuvanted Seasonal Influenza Vaccine In Adults 65 Years And Older In Clinical Infectious Diseases

Terumo Blood And Cell Technologies And CSL Plasma Announce Collaboration To Deliver New Plasma Collection Platform

Carlisle Companies Publishes 2020 Sustainability Report And Launches New Website Focused On ESG

Carlisle Companies To Announce First Quarter 2021 Results On April 22, 2021

Carlisle Celebrates 50th Anniversary Of Its Proprietary TyrFil Flatproofing Technology

Seqirus Announces U.S. FDA Approval Of Expanded Age Indication Of Its Cell-Based Quadrivalent Influenza Vaccine For People Two Years Of Age And Older

Carlisle Companies Announces Leadership Changes In Finance

Carlisle Companies Authorizes Repurchase Of An Additional 5 Million Shares

Carlisle Companies Declares Regular Quarterly Dividend

Lyfebulb And CSL Behring Launch TransplantLyfe, A First-of-its-Kind Community Engagement Platform For Transplant Patients

Carlisle Companies To Announce Fourth Quarter 2020 Results On February 4, 2021

Lyfebulb Announces Call-to-Action For Submissions To The 2021 Innovation Challenge: Thriving With Transplantation

Carlisle Companies Announces Leadership Appointments In Human Resources And Finance

Carlisle Companies Announces New Executive Role, Vice President, Sustainability

Seqirus Presents New Late-Breaking Data At ESWI 2020 Highlighting Benefits Of MF59®-Adjuvanted Seasonal Influenza Vaccine

New Harris Poll Survey Finds Vast Majority Of People Living With Hereditary Angioedema (HAE) Value Efficacy And Specific Correction Of C1-INH Deficiency When Choosing An HAE Therapy

Urban League, CSL Behring Partner To Address Community Needs Including Public Health, Workforce Diversity, Leadership Development